Pair each described clinical testing scenario or modification with the corresponding impact it has on the diagnostic test's performance metrics.
- Selecting to utilize a continuous biomarker in a high-risk specialty clinic rather than for general population screeningAugments the positive predictive value (PPV) and reduces the negative predictive value (NPV) without changing intrinsic test accuracy
- Modifying a diagnostic assay to use a lower numeric threshold for a positive result to minimize missed casesEnhances test sensitivity while concurrently decreasing specificity, thereby generating a higher proportion of false-positive results
- Adjusting a biomarker's diagnostic threshold upwards to ensure absolute certainty before proceeding with a dangerous surgical interventionDiminishes test sensitivity while concurrently increasing specificity, thereby generating a higher proportion of false-negative results
- Implementing a broad screening initiative for a remarkably rare condition among entirely asymptomatic individualsCauses a decrease in the positive predictive value (PPV) and an increase in the negative predictive value (NPV) without changing intrinsic test accuracy
Answer
Testing in a high-risk population increases PPV/decreases NPV; lowering the cutoff increases sensitivity/decreases specificity; raising the cutoff decreases sensitivity/increases specificity; screening an asymptomatic population decreases PPV/increases NPV.
Prevalence directly impacts predictive values (PPV and NPV) while leaving sensitivity and specificity unchanged. Conversely, adjusting a diagnostic cutoff alters the test's intrinsic characteristics (sensitivity and specificity), which subsequently impacts predictive values.
Step-by-Step Solution
Key Concept
The effect of prevalence on predictive values and the inverse relationship between sensitivity and specificity when adjusting diagnostic cutoffs.